Assessing the Relationship between Health Utilities, Quality of Life, and Health Care Costs in Alzheimer's Disease: The CATIE-AD Study

2010 ◽  
Vol 999 (999) ◽  
pp. 1-10
Author(s):  
Edward Alan Miller ◽  
Robert A. Rosenheck ◽  
Lon S. Schneider
Keyword(s):  
Quality Of Life ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Health Care ◽  
Health Care Costs ◽  
Health Utilities ◽  
The Relationship ◽  
Care Costs

Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom

2020 ◽  
Author(s):  
Stephen Rice ◽  
Viviana Albani ◽  
Dimitrios Minos ◽  
Gulnar Fattakhova ◽  
George F. Mells ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
United Kingdom ◽  
Health Care Costs ◽  
Primary Biliary Cholangitis ◽  
The United Kingdom ◽  
Care Costs

Health-Related Quality of Life in Patients with Alzheimer’s Disease in Different German Health Care Settings

2016 ◽  
Vol 51 (2) ◽  
pp. 545-561 ◽  
Author(s):  
Philipp Heßmann ◽  
Greta Seeberg ◽  
Jens Peter Reese ◽  
Judith Dams ◽  
Erika Baum ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Health Care ◽  
Health Related Quality ◽  
Health Care Settings ◽  
German Health ◽  
Related Quality ◽  
Health Related

scholarly journals Cerebral palsy in Canada, 2011-2031: results of a microsimulation modelling study of epidemiological and cost impacts

2020 ◽  
Vol 40 (2) ◽  
pp. 25-37
Author(s):  
Nana Amankwah ◽  
Maryam Oskoui ◽  
Rochelle Garner ◽  
Christina Bancej ◽  
Douglas G. Manuel ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Cerebral Palsy ◽  
Health Care Costs ◽  
Health Related Quality ◽  
Incidence And Mortality ◽  
Related Quality ◽  
Health Related ◽  
Care Costs

Introduction The objective of our study was to present model-based estimates and projections on current and future health and economic impacts of cerebral palsy in Canada over a 20-year time horizon (2011–2031). Methods We used Statistics Canada’s Population Health Model (POHEM)–Neurological to simulate individuals’ disease states, risk factors and health determinants and to describe and project health outcomes, including disease incidence, prevalence, life expectancy, health-adjusted life expectancy, health-related quality of life and health care costs over the life cycle of Canadians. Cerebral palsy cases were identified from British Columbia’s health administrative data sources. A population-based cohort was then used to generate the incidence and mortality rates, enabling the projection of future incidence and mortality rates. A utility-based measure (Health Utilities Index Mark 3) was also included in the model to reflect various states of functional health to allow projections of health-related quality of life. Finally, we estimated caregiving parameters and health care costs from Canadian national surveys and health administrative data and included them as model parameters to assess the health and economic impact of cerebral palsy. Results Although the overall crude incidence rate of cerebral palsy is projected to remain stable, newly diagnosed cases of cerebral palsy will rise from approximately 1800 in 2011 to nearly 2200 in 2031. In addition, the number of people with the condition is expected to increase from more than 75 000 in 2011 to more than 94 000 in 2031. Direct health care costs in constant 2010 Canadian dollars were about $11 700 for children with cerebral palsy aged 1–4 years versus about $600 for those without the condition. In addition, people with cerebral palsy tend to have longer periods in poorer health-related quality of life. Conclusion Individuals with cerebral palsy will continue to face challenges related to an ongoing need for specialized medical care and a rising need for supportive services. Our study offers important insights into future costs and impacts associated with cerebral palsy and provides valuable information that could be used to develop targeted health programs and strategies for Canadians living with this condition.

The lower the quality of life the higher health care costs in irritable Bowel syndrome

2001 ◽  
Vol 120 (5) ◽  
pp. A636
Author(s):  
Paul Enck ◽  
Petra Ilgenstein ◽  
Andrea Spannheimer ◽  
Bertold Ries ◽  
Olaf Pirk
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Irritable Bowel Syndrome ◽  
Health Care Costs ◽  
Irritable Bowel ◽  
Care Costs
Sign in / Sign up

Export Citation Format

Share Document